These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21914636)

  • 21. Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-
    Dai X; He J; Zhang R; Wu G; Xiong F; Zhao B
    Int J Nanomedicine; 2017; 12():6617-6632. PubMed ID: 28924346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.
    Gupta PN; Khatri K; Goyal AK; Mishra N; Vyas SP
    J Drug Target; 2007 Dec; 15(10):701-13. PubMed ID: 18041638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel vehicle for local protein delivery to the inner ear: injectable and biodegradable thermosensitive hydrogel loaded with PLGA nanoparticles.
    Dai J; Long W; Liang Z; Wen L; Yang F; Chen G
    Drug Dev Ind Pharm; 2018 Jan; 44(1):89-98. PubMed ID: 28851247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of mucoadhesive PLGA microparticles for nasal immunization.
    Pawar D; Goyal AK; Mangal S; Mishra N; Vaidya B; Tiwari S; Jain AK; Vyas SP
    AAPS J; 2010 Jun; 12(2):130-7. PubMed ID: 20077052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
    Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
    Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity.
    Gomes AJ; Espreafico EM; Tfouni E
    Mol Pharm; 2013 Oct; 10(10):3544-54. PubMed ID: 23865934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
    J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
    Sankar R; Ravikumar V
    Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannose-Modified PLGA Nanoparticles for Sustained and Targeted Delivery in Hepatitis B Virus Immunoprophylaxis.
    Zhu J; Qin F; Ji Z; Fei W; Tan Z; Hu Y; Zheng C
    AAPS PharmSciTech; 2019 Dec; 21(1):13. PubMed ID: 31807947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
    Jeon SY; Park JS; Yang HN; Woo DG; Park KH
    Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent.
    Wang CW; Yang SP; Hu H; Du J; Li FH
    Mol Med Rep; 2015 Mar; 11(3):1885-90. PubMed ID: 25394467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.